EKF Diagnostics’ novel viral transport media PrimeStore MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England (PHE). To work safely with live SARS-CoV-2 samples requires the use of high-containment laboratories. However, after inactivation SARS-CoV-2 material can be handled at a lower containment level, allowing more laboratories to undertake testing and thereby increasing COVID-19 testing capacity.
The PHE study evaluated numerous commercially available reagents and laboratory formulations commonly used for viral inactivation protocols by public health agencies and research laboratories globally. All the reagents tested have been used during the current COVID-19 pandemic for sample transportation and subsequent molecular processing. A total of 23 commercial reagents designed for virus inactivation, clinical sample transportation and nucleic acid extraction were assessed by PHE for their ability to inactivate SARS-CoV-2.
The study used TCID50 and blind passage techniques to test for any infectious virus still recoverable from all samples treated with the inactivation reagents. Notably, the study showed that PrimeStore MTM was the only commercially available transport reagent from the many tested from which no residual virus was detectable by either TCID50 or by the passaging of treated purified sample. This demonstrates the efficacy and safety of PrimeStore MTM in inactivating live SARS-CoV-2 samples whilst maintaining the ability to detect the target viral RNA.
In addition to this successful PHE evaluation of its effectiveness at deactivating SARS-CoV-2, PrimeStore MTM is also an FDA cleared and CE-IVD marked sample collection device. PrimeStore MTM removes the need for all cold chain logistics including sample storage; RNA and DNA are perfectly preserved for downstream molecular processing for up to four weeks at room temperature. Furthermore, because samples are rapidly inactivated, the risk of infection is eliminated, meaning samples are ready for safe testing immediately on arrival at a laboratory.
For more information, visit: www.ekfdiagnostics.com Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/7_PRODUCT_EKF.jpg45110003wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-12-23 00:00:002020-12-23 00:00:00PrimeStore MTM novel viral transport media successfully evaluated by Public Health England for SARS-CoV-2 inactivation
Randox Laboratories has unveiled Randox Discovery, a revolutionary COVID-19 diagnostic analyser. The benchtop laboratory for molecular and immunoassay diagnostics is the first of its kind to combine sample preparation techniques and Biochip Technology – a patented multiplex testing platform – in one high throughput fully-automated analyser.
Randox’s patented Biochip Technology allows simultaneous detection of hundreds of targets from a single sample. The technology is capable of detecting SARS-CoV-2 and differentiating between other respiratory pathogens with similar symptoms. It can detect all known strains of coronavirus comprising SARS-CoV-2, Sarbecovirus (SARS, SARS-like & SARS-CoV-2), coronavirus 229E, coronavirus NL63, coronavirus OC43 and coronavirus HKUI.
The combination of both SARS-CoV-2 and Sarbecovirus on the panel provides added confidence in patient diagnosis and helps to reduce false positives or negatives. This ultimately enables better treatment decisions and allows for more effective isolation and de-isolation of suspected and confirmed cases.
The Discovery has a rapid turnaround time with three hours to first batch of results and results for subsequent batches every hour after.
It is fully automated enabling a single operator to run up to 3 Discovery analysers.
For more information, visit: www.randox.com/randox-discovery/ Read more
DiaSys has launched a fluid-stable, particleenhanced immunoturbidimetric assay for determination of procalcitonin (PCT) in serum and plasma on clinical chemistry analysers.
Procalcitonin FS offers high precision at clinical cut-off levels for sepsis with a measuring range from 0.2 ng/mL to 50 ng/mL. Procalcitonin FS has an outstanding onboard and calibration stability. No prozone effect was observed up to 1000 ng/mL.
The assay performance is complemented by high tolerance to endogenous interferents and common therapeutics used in sepsis management. Method comparisons of Procalcitonin FS show good comparability to established tests and present the new assay as a reliable alternative for clinical chemistry analysers.
For more information, visit: www.diasys-diagnostics.com/products/reagents/ immunoturbidimetry/reagent-details/227- procalcitonin-fs/reagent.show Read more
BD (Becton, Dickinson and Company), a leading global medical technology company, has received 510(k) clearance from the U.S. FDA for the BD FACSLyric™ Flow Cytometer with the Integrated BD FACSDuet™ Sample Preparation System.
The new integrated system enables clinical laboratories to fully automate the sample to answer process and improve their efficiency by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric™ Flow Cytometer.
The BD FACSDuet Sample Preparation System builds new capabilities into the BD portfolio of clinical flow cytometry solutions offering a pre-analytical system, that combined with the BD FACSLyric Flow Cytometer is the first truly walkaway sample-to-answer solution for clinical labs.
Physical integration between the BD FACSDuet Sample Preparation System and the BD FACSLyric Flow Cytometer allows technicians to load samples and reagents’ samples are acquired and analysed on the BD FACSLyric Flow Cytometer. Data integration using the BD FACSLink™ Middleware Solution offers bidirectional communication between the instruments and connectivity with laboratory information systems.
The BD FACSLyric™ Flow Cytometer with the integrated BD FACSDuet™ Sample Preparation System is now available as an in vitro diagnostic (IVD) system in the United States as well as countries recognizing the CE-IVD certification, which was achieved in March 2019.
For more information, visit: www.bdbiosciences.com/en-us/instruments/ clinical-instruments/clinical-cell-analyzers/facslyric Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/3_PRODUCT_BD.jpg50110003wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-12-23 00:00:002020-12-23 00:00:00BD granted FDA clearance for BD FACSLyric Flow Cytometer with newly integrated BD FACSDuet Sample Preparation System
Bio-Rad Laboratories, a global leader of life science research and clinical diagnostic products, has introduced StarBright Violet 515 (SBV515) Dye, the first of a new range of unique fluorescent nanoparticles, for use in flow cytometry. Star- Bright Dyes are conjugated to a growing range of antibodies and are compatible with most flow cytometers and experimental protocols.
The StarBright Violet 515 Dye with an excitation maximum at 401 nanometre and emission maximum of 516 nanometre offers researchers improved brightness to resolve rare and low antigen density populations more easily. It has a narrow emission profile to reduce spillover into neighbouring filters and minimal excitation by other lasers, making it suitable for inclusion in multicolour panels.
The dye is not susceptible to photobleaching, delivers high lot-to-lot reproducibility, and is stable at 4°C with no loss of signal to help ensure consistent staining and deliver reliable results. It has been tested in many common staining buffers and there is no requirement to use a special staining buffer, permitting easy integration into common experimental protocols without compromising performance. StarBright Violet 515 Dye is compatible with Bio-Rad’s ZE5 Cell Analyzer, S3e Cell Sorter, as well as other cytometers, and it is suitable for both conventional and spectral flow.
Mike Blundell, Bio-Rad Product Manager, Life Science Group, commented: “StarBright Violet 515 Dye is brighter than other common dyes that emit at similar wavelengths. The dye is flexible enough to fit into any flow cytometry panel, allowing researchers to multiplex with ease regardless of flow cytometer and experimental protocol, and it offers a superior alternative for fluorophores that have emission maxima between 500 and 550 nanometres.”
For more information, visit: www.bio-rad-antibodies.com/starbright Read more
Promega has launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system is an integrated DNA analysis instrument that enables life scientists in laboratories of all sizes to perform Sanger sequencing and fragment analysis at the bench.
The Spectrum Compact CE System features:
flexible run scheduling
easy-to-use interface
convenient benchtop size
separate plug-and-play consumables
on-site installation and operational training
The instrument supports applications such as microsatellite instability analysis, mixed sample analysis, forensic STR analysis, and cell line authentication. It processes up to 32 samples in a single run and can be controlled by either the integrated touchscreen or by additional software that allows access from any registered computer on the same network. Guided software brings capillary electrophoresis capabilities to the hands of any scientist in the laboratory regardless of skill level.
“The Spectrum Compact CE is personal and that’s one of the huge advantages that scientists will see with this instrument,” commented Doug Storts, Promega Head of Research. “An individual can walk into the laboratory and with minimal training, be able to change all the consumables, select which chemistries they want to use for both DNA sequencing as well as for fragment analysis, and perform the experiment.”
Promega is also offering extensive support to laboratories integrating a Spectrum Compact CE System into their workflow, including on-site instrument and software installation and operational training. Technical Services Scientists are prepared to assist with data analysis and summary reports, and Field Support and Validation Services Scientists are available to assist with maintenance and validation requirements.
For more information, visit: www.promega.com/SpectrumCompactCE Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/9C_PRODUCT_PROMEGA.jpg6306213wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-12-23 00:00:002020-12-23 00:00:00Promega introduces Spectrum Compact CE benchtop DNA analysis instrument with Hitachi High-Tech
The new EUROPattern Microscope Live from Euroimmun provides state-of-the-art on-screen immunofluorescence microscopy with automated evaluation of results using AI processes. The immunofluorescence images are acquired rapidly in less than two seconds per image using novel automatic laser focusing.
The compact microscope includes an integrated controlled LED and fluorescence standard for constant illumination, ensuring standardised quality for microscopes at different locations. The images are recorded by means of a highresolution camera. The captured images are classified as positive, negative or borderline by means of deep-learning processes using deep convolutional neural networks. The system also incorporates pattern recognition for anti-nuclear antibodies (ICAP compliant).
Immunofluorescence evaluation applications are also available. DataMatrix codes on the slides ensure reliable assignment of the samples to their corresponding results. The middleware EUROLabOffice 4.0 provides state-of-the-art digital laboratory organisation with intelligent interconnection of different workstations and different locations. The software communicates continuously with the LIS and laboratory instruments, ensuring reliable, traceable and rapid data exchange.
Predefinable workflows and automatically generated protocols enable efficient organi -sation of the daily workload. Results from different workstations are consolidated for each patient and presented with the patient history and all fluorescence images. Patient data, customer details and article information are all administered and archived by the system. The software is simple and intuitive to operate, with no unnecessary manual steps, thus saving time and reducing workload for laboratory staff. The clear user interface makes it ideal for all workplaces, including the laboratory microscopy room and office.
For more information, visit: www.euroimmun.com Read more
DiaSys Diagnostic Systems has launched respons940 to complement the respons system family. This clinical chemistry analyser has a true throughput of 640 test/h including ISE measurements. With durable hard glass cuvettes, low reaction volumes, maintenance free photometer and intuitively operated software, respons940 offers the economic use required in medium sized laboratories.
Dedicated respons system reagent kits including CE marked applications and carry over evasion lists ensure highest result security combined with the ease of use of the respons analysers.
For more information, visit: www.diasys-diagnostics.com/products/instruments/responsr940/ Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/2A_PRODUCT_DIASYS.jpg7826183wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-12-23 00:00:002020-12-23 00:00:00DiaSys Diagnostic Systems launches respons940 – a clinical chemistry analyser for medium-sized labs
TRIMERO Diagnostics offers an IVD CE marked assay for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems.
Main features of the assay are:
specifically developed for IMMAGE® and IMMAGE® 800 nephelometers
values traced to the Serum Amyloid A (SAA) 1st International Standard (NIBSC code: 92/680) of the WHO (World Health Organization).
SAA turbidimetric assays are also available for the most popular clinical chemistry analysers.
Other available assays for IMMAGE® nephelometers and turbidimetry include: KLoneus® Free Light Chains (FLC) for serum and urine, Beta-2 Microglobulin for serum and urine, IgD Immunoglobulins, Retinol Binding Protein (RBP) for serum and urine, Soluble Transferrin Receptor (sTfR), Hemopexin, Cystatin-C for serum and urine, A1-Microglobulin, Kappa and Lambda Light Chains for serum and urine, Complement C1q, Complement C5, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor.
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/CLI_201021_doc_image_SAA-800.jpg8837223wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-12-23 00:00:002020-12-23 00:00:00Serum Amyloid A (SAA) nephelometric assay, for IMMAGE® Immunochemical Systems
As COVID-19 continues to impact countries worldwide, accurate screening is needed to establish serological status of different populations. Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay, for the detection of total anti-nucleocapsid antibodies (IgM, IgA, IgG) to SARS-CoV-2. In one test, the assay helps identify the immune response to coronavirus SARS-CoV-2, the virus associated with COVID-19.
For more information, visit: https://info.bio-rad.com/cdg-sars-cov-2-ous?WT.mc_id=201012029377 Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png003wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-12-23 00:00:002020-12-23 00:00:00Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
PrimeStore MTM novel viral transport media successfully evaluated by Public Health England for SARS-CoV-2 inactivation
, /in Product News /by 3wmediaEKF Diagnostics’ novel viral transport media PrimeStore MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England (PHE). To work safely with live SARS-CoV-2 samples requires the use of high-containment laboratories. However, after inactivation SARS-CoV-2 material can be handled at a lower containment level, allowing more laboratories to undertake testing and thereby increasing COVID-19 testing capacity.
The PHE study evaluated numerous commercially available reagents and laboratory formulations commonly used for viral inactivation protocols by public health agencies and research laboratories globally. All the reagents tested have been used during the current COVID-19 pandemic for sample transportation and subsequent molecular processing. A total of 23 commercial reagents designed for virus inactivation, clinical sample transportation and nucleic acid extraction were assessed by PHE for their ability to inactivate SARS-CoV-2.
The study used TCID50 and blind passage techniques to test for any infectious virus still recoverable from all samples treated with the inactivation reagents. Notably, the study showed that PrimeStore MTM was the only commercially available transport reagent from the many tested from which no residual virus was detectable by either TCID50 or by the passaging of treated purified sample. This demonstrates the efficacy and safety of PrimeStore MTM in inactivating live SARS-CoV-2 samples whilst maintaining the ability to detect the target viral RNA.
In addition to this successful PHE evaluation of its effectiveness at deactivating SARS-CoV-2, PrimeStore MTM is also an FDA cleared and CE-IVD marked sample collection device. PrimeStore MTM removes the need for all cold chain logistics including sample storage; RNA and DNA are perfectly preserved for downstream molecular processing for up to four weeks at room temperature. Furthermore, because samples are rapidly inactivated, the risk of infection is eliminated, meaning samples are ready for safe testing immediately on arrival at a laboratory.
For more information, visit: www.ekfdiagnostics.com
Read more
Randox Labs unveils ‘All in One’ COVID-19 diagnostic analyser
, /in Product News /by 3wmediaRandox Laboratories has unveiled Randox Discovery, a revolutionary COVID-19 diagnostic analyser. The benchtop laboratory for molecular and immunoassay diagnostics is the first of its kind to combine sample preparation techniques and Biochip Technology – a patented multiplex testing platform – in one high throughput fully-automated analyser.
Randox’s patented Biochip Technology allows simultaneous detection of hundreds of targets from a single sample. The technology is capable of detecting SARS-CoV-2 and differentiating between other respiratory pathogens with similar symptoms. It can detect all known strains of coronavirus comprising SARS-CoV-2, Sarbecovirus (SARS, SARS-like & SARS-CoV-2), coronavirus 229E, coronavirus NL63, coronavirus OC43 and coronavirus HKUI.
The combination of both SARS-CoV-2 and Sarbecovirus on the panel provides added confidence in patient diagnosis and helps to reduce false positives or negatives. This ultimately enables better treatment decisions and allows for more effective isolation and de-isolation of suspected and confirmed cases.
The Discovery has a rapid turnaround time with three hours to first batch of results and results for subsequent batches every hour after.
It is fully automated enabling a single operator to run up to 3 Discovery analysers.
For more information, visit: www.randox.com/randox-discovery/
Read more
DiaSys introduces Procal-citonin FS fluid-stable, particle-enhanced immunoturbidimetric assay
, /in Product News /by 3wmediaDiaSys has launched a fluid-stable, particleenhanced immunoturbidimetric assay for determination of procalcitonin (PCT) in serum and plasma on clinical chemistry analysers.
Procalcitonin FS offers high precision at clinical cut-off levels for sepsis with a measuring range from 0.2 ng/mL to 50 ng/mL. Procalcitonin FS has an outstanding onboard and calibration stability. No prozone effect was observed up to 1000 ng/mL.
The assay performance is complemented by high tolerance to endogenous interferents and common therapeutics used in sepsis management. Method comparisons of Procalcitonin FS show good comparability to established tests and present the new assay as a reliable alternative for clinical chemistry analysers.
For more information, visit: www.diasys-diagnostics.com/products/reagents/ immunoturbidimetry/reagent-details/227- procalcitonin-fs/reagent.show
Read more
BD granted FDA clearance for BD FACSLyric Flow Cytometer with newly integrated BD FACSDuet Sample Preparation System
, /in Product News /by 3wmediaBD (Becton, Dickinson and Company), a leading global medical technology company, has received 510(k) clearance from the U.S. FDA for the BD FACSLyric™ Flow Cytometer with the Integrated BD FACSDuet™ Sample Preparation System.
The new integrated system enables clinical laboratories to fully automate the sample to answer process and improve their efficiency by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric™ Flow Cytometer.
The BD FACSDuet Sample Preparation System builds new capabilities into the BD portfolio of clinical flow cytometry solutions offering a pre-analytical system, that combined with the BD FACSLyric Flow Cytometer is the first truly walkaway sample-to-answer solution for clinical labs.
Physical integration between the BD FACSDuet Sample Preparation System and the BD FACSLyric Flow Cytometer allows technicians to load samples and reagents’ samples are acquired and analysed on the BD FACSLyric Flow Cytometer. Data integration using the BD FACSLink™ Middleware Solution offers bidirectional communication between the instruments and connectivity with laboratory information systems.
The BD FACSLyric™ Flow Cytometer with the integrated BD FACSDuet™ Sample Preparation System is now available as an in vitro diagnostic (IVD) system in the United States as well as countries recognizing the CE-IVD certification, which was achieved in March 2019.
For more information, visit: www.bdbiosciences.com/en-us/instruments/ clinical-instruments/clinical-cell-analyzers/facslyric
Read more
Bio-Rad introduces StarBright Violet 515 Dye for flow cytometry
, /in Product News /by 3wmediaBio-Rad Laboratories, a global leader of life science research and clinical diagnostic products, has introduced StarBright Violet 515 (SBV515) Dye, the first of a new range of unique fluorescent nanoparticles, for use in flow cytometry. Star- Bright Dyes are conjugated to a growing range of antibodies and are compatible with most flow cytometers and experimental protocols.
The StarBright Violet 515 Dye with an excitation maximum at 401 nanometre and emission maximum of 516 nanometre offers researchers improved brightness to resolve rare and low antigen density populations more easily. It has a narrow emission profile to reduce spillover into neighbouring filters and minimal excitation by other lasers, making it suitable for inclusion in multicolour panels.
The dye is not susceptible to photobleaching, delivers high lot-to-lot reproducibility, and is stable at 4°C with no loss of signal to help ensure consistent staining and deliver reliable results. It has been tested in many common staining buffers and there is no requirement to use a special staining buffer, permitting easy integration into common experimental protocols without compromising performance. StarBright Violet 515 Dye is compatible with Bio-Rad’s ZE5 Cell Analyzer, S3e Cell Sorter, as well as other cytometers, and it is suitable for both conventional and spectral flow.
Mike Blundell, Bio-Rad Product Manager, Life Science Group, commented: “StarBright Violet 515 Dye is brighter than other common dyes that emit at similar wavelengths. The dye is flexible enough to fit into any flow cytometry panel, allowing researchers to multiplex with ease regardless of flow cytometer and experimental protocol, and it offers a superior alternative for fluorophores that have emission maxima between 500 and 550 nanometres.”
For more information, visit: www.bio-rad-antibodies.com/starbright
Read more
Promega introduces Spectrum Compact CE benchtop DNA analysis instrument with Hitachi High-Tech
, /in Product News /by 3wmediaPromega has launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system is an integrated DNA analysis instrument that enables life scientists in laboratories of all sizes to perform Sanger sequencing and fragment analysis at the bench.
The Spectrum Compact CE System features:
The instrument supports applications such as microsatellite instability analysis, mixed sample analysis, forensic STR analysis, and cell line authentication. It processes up to 32 samples in a single run and can be controlled by either the integrated touchscreen or by additional software that allows access from any registered computer on the same network. Guided software brings capillary electrophoresis capabilities to the hands of any scientist in the laboratory regardless of skill level.
“The Spectrum Compact CE is personal and that’s one of the huge advantages that scientists will see with this instrument,” commented Doug Storts, Promega Head of Research. “An individual can walk into the laboratory and with minimal training, be able to change all the consumables, select which chemistries they want to use for both DNA sequencing as well as for fragment analysis, and perform the experiment.”
Promega is also offering extensive support to laboratories integrating a Spectrum Compact CE System into their workflow, including on-site instrument and software installation and operational training. Technical Services Scientists are prepared to assist with data analysis and summary reports, and Field Support and Validation Services Scientists are available to assist with maintenance and validation requirements.
For more information, visit: www.promega.com/SpectrumCompactCE
Read more
Automated immunofluorescence microscopy incorporating artificial intelligence
, /in Product News /by 3wmediaThe new EUROPattern Microscope Live from Euroimmun provides state-of-the-art on-screen immunofluorescence microscopy with automated evaluation of results using AI processes. The immunofluorescence images are acquired rapidly in less than two seconds per image using novel automatic laser focusing.
The compact microscope includes an integrated controlled LED and fluorescence standard for constant illumination, ensuring standardised quality for microscopes at different locations. The images are recorded by means of a highresolution camera. The captured images are classified as positive, negative or borderline by means of deep-learning processes using deep convolutional neural networks. The system also incorporates pattern recognition for anti-nuclear antibodies (ICAP compliant).
Immunofluorescence evaluation applications are also available. DataMatrix codes on the slides ensure reliable assignment of the samples to their corresponding results. The middleware EUROLabOffice 4.0 provides state-of-the-art digital laboratory organisation with intelligent interconnection of different workstations and different locations. The software communicates continuously with the LIS and laboratory instruments, ensuring reliable, traceable and rapid data exchange.
Predefinable workflows and automatically generated protocols enable efficient organi -sation of the daily workload. Results from different workstations are consolidated for each patient and presented with the patient history and all fluorescence images. Patient data, customer details and article information are all administered and archived by the system. The software is simple and intuitive to operate, with no unnecessary manual steps, thus saving time and reducing workload for laboratory staff. The clear user interface makes it ideal for all workplaces, including the laboratory microscopy room and office.
For more information, visit: www.euroimmun.com
Read more
DiaSys Diagnostic Systems launches respons940 – a clinical chemistry analyser for medium-sized labs
, /in Product News /by 3wmediaDiaSys Diagnostic Systems has launched respons940 to complement the respons system family. This clinical chemistry analyser has a true throughput of 640 test/h including ISE measurements. With durable hard glass cuvettes, low reaction volumes, maintenance free photometer and intuitively operated software, respons940 offers the economic use required in medium sized laboratories.
Dedicated respons system reagent kits including CE marked applications and carry over evasion lists ensure highest result security combined with the ease of use of the respons analysers.
For more information, visit: www.diasys-diagnostics.com/products/instruments/responsr940/
Read more
Serum Amyloid A (SAA) nephelometric assay, for IMMAGE® Immunochemical Systems
, /in Product News /by 3wmediaTRIMERO Diagnostics offers an IVD CE marked assay for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems.
Main features of the assay are:
SAA turbidimetric assays are also available for the most popular clinical chemistry analysers.
Other available assays for IMMAGE® nephelometers and turbidimetry include: KLoneus® Free Light Chains (FLC) for serum and urine, Beta-2 Microglobulin for serum and urine, IgD Immunoglobulins, Retinol Binding Protein (RBP) for serum and urine, Soluble Transferrin Receptor (sTfR), Hemopexin, Cystatin-C for serum and urine, A1-Microglobulin, Kappa and Lambda Light Chains for serum and urine, Complement C1q, Complement C5, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor.
Read more
Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay
, /in Product News /by 3wmediaAs COVID-19 continues to impact countries worldwide, accurate screening is needed to establish serological status of different populations. Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay, for the detection of total anti-nucleocapsid antibodies (IgM, IgA, IgG) to SARS-CoV-2. In one test, the assay helps identify the immune response to coronavirus SARS-CoV-2, the virus associated with COVID-19.
For more information, visit: https://info.bio-rad.com/cdg-sars-cov-2-ous?WT.mc_id=201012029377
Read more